Circulating miR-320b Contributes to CD4+ T-Cell Proliferation in Systemic Lupus Erythematosus via MAP3K1

Figure 1

Circulating miR-320b is decreased after MSCT in SLE patients and associated with disease activity. (a) miR-320b expression in plasma and PBMCs of SLE patients before and after receiving MSCT. Plasma, n = 32; PBMC, n = 7. (b) Expression levels and ROC curve of circulating miR-320b in HC and SLE groups. HC, n = 30; SLE, n = 46. (c) Association of circulating miR-320b expression with the SLEDAI score of SLE patients. HC, healthy control; MSCT, mesenchymal stem cell transplantation; ROC, receiver operating characteristic; SLEDAI, systemic lupus erythematosus disease activity index. , .

(a)

(b)

(c)